This circuit consists of two interactive modules, namely the oncogenic TF-driven CRISPRa effector (AND gate) and the corresponding p53-induced shut-off switch (NOT gate), working together to implement accurate tumor targeting through AND-NOT logic. The gene discussed is TP53; the disease is neoplasm.